SCHEMBL24933810

SCHEMBL24933810

NC(=O)c1cc(-c2ccc(OCc3cnc(C4CC4)nc3)cc2)c(C(F)(F)F)[nH]c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.40
GRM2 Q14416 1/20 0.39
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
MAOB P27338 2/20 0.36
NR1H4 Q96RI1 1/20 0.35
PRMT5 O14744 1/20 0.35
HDAC3 O15379 1/20 0.35
PARP1 P09874 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HSD17B1 P14061 5/20 0.35
HSD17B2 P37059 5/20 0.35
KIT P10721 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933385 0.89 PARP1 (0.39) HDAC1HDAC6HDAC5MAOBHDAC3
SCHEMBL24933268 0.88 PRMT5 (0.40) FFAR4MAOBNR1H4PRMT5HSD17B1
SCHEMBL30240676 0.88 PRMT5 (0.40) FFAR4MAOBNR1H4PRMT5HSD17B1
SCHEMBL24932987 0.88 SYK (0.40) MAOBPARP1HSD17B1HSD17B2KIT
SCHEMBL24933227 0.87 BRS3 (0.37) GRM2HDAC1HDAC6HDAC5MAOB
SCHEMBL24933795 0.87 MKNK1 (0.35) FFAR4HDAC1HDAC6HDAC5MAOB
SCHEMBL24933463 0.87 HSD17B1 (0.41) HDAC1HDAC6HDAC5MAOBPRMT5
SCHEMBL24933812 0.86 SYK (0.39)
SCHEMBL24933213 0.86 MAOB (0.36) HDAC1HDAC6HDAC5MAOBHDAC3
SCHEMBL24933216 0.85 HSD17B1 (0.36) HDAC1HDAC6HDAC5MAOBHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed